The purpose of this study is to test the efficacy of a newly developed active vaccine against
cocaine (TA-CD).
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
Celtic Pharma Development Services Columbia University Johns Hopkins University National Institute on Drug Abuse (NIDA) University of Cincinnati University of Pennsylvania US Department of Veterans Affairs Cooperative Studies Program VA Maryland Health Care System VA New York Harbor Healthcare System